Device Trial Radar · NCT00861354
Home Monitoring for Atrial Fibrillation Using a Microlife Blood Pressure Monitor
Last checked: Nov 20, 2026Latest source record: Jan 8, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
150
Planned (sponsor's estimate)
Start
Mar 2009
Primary completion
Sep 2009
Study completion Sep 2009
Sponsor
- Lead sponsor
- MicrolifeNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 13, 2009
Design
- Study type
- Observational
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study assess the accuracy of a blood pressure monitor designed to detect atrial fibrillation. Subjects use the blood pressure monitor on a daily basis for 30 days and compare the readings to an ECG done at the same time.
Conditions
- Atrial Fibrillation
Interventions
Microlife blood pressure monitor with AF detection (Microlife AFIB MLU3MQ1)Device
Monitoring heart rhythm daily for 30 days using the blood pressure monitor and the ECG recorder.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity and specificity of the blood pressure monitor used for detecting atrial fibrillation compared to the electrocardiogram.Time frame: After final subject data is available.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Joseph Wiesel, MD medical office
Flushing, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.